Home532488 • BOM
add
Divi's Laboratories Ltd
Previous close
₹6,111.90
Day range
₹6,051.05 - ₹6,125.00
Year range
₹3,725.55 - ₹6,448.75
Market cap
1.63T INR
Avg Volume
19.31K
P/E ratio
78.62
Dividend yield
0.49%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 23.19B | 25.01% |
Operating expense | 7.53B | 2.87% |
Net income | 5.89B | 64.53% |
Net profit margin | 25.40 | 31.61% |
Earnings per share | 22.39 | 65.85% |
EBITDA | 7.38B | 54.10% |
Effective tax rate | 18.87% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.02B | -0.25% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 137.17B | — |
Shares outstanding | 265.32M | — |
Price to book | 11.84 | — |
Return on assets | — | — |
Return on capital | 11.73% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 5.89B | 64.53% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
Founded
Oct 12, 1990
Website
Employees
9,741
